ARTICLE | Company News
Immunex, CAT in antibody deal
May 21, 2001 7:00 AM UTC
IMNX and Cambridge Antibody Technology (LSE:CAT) will develop monoclonal antibodies for autoimmune and inflammatory diseases. IMNX will contribute two targets and CAT will contribute its human antibod...